Q&A: The risks of brain bleeds in antibody treatments for Alzheimer’s disease

Ryan Institute Co-Executive Director William Van Nostrand answers questions about the potential risk of brain bleeds associated with newly-approved lecanemab and similar treatments. This summer, the FDA granted full approval to lecanemab, an antibody treatment for Alzheimer’s disease.  The antibody—a protein that works by clearing amyloid-beta protein “plaques” in the brain, a signature of Alzheimer’s disease—has […]

Continue reading "Q&A: The risks of brain bleeds in antibody treatments for Alzheimer’s disease"

People

    Postdoc Graduate Students Undergraduate Students Liviana Donatelli (INP, Psy) Alex Burns (INP) Bhavya Chatragadda (INP, CMB-microbiology) Emilie Gastone (CMB) Past members – Undergrads Tinu Oladele  Kofo Adebiyi Elizabeth Murphy

Continue reading "People"

New affiliated faculty members join the Ryan Institute

The Ryan Institute was pleased to welcome ten new faculty affiliates in Spring 2023 from the College of Pharmacy, College of Health Sciences, and College of Electrical, Computer, and Biomedical Engineering. Specializing in research areas that complement the institute’s focus on pathogenic mechanisms of neurodegenerative disease, our URI network of affiliated faculty are valuable partners […]

Continue reading "New affiliated faculty members join the Ryan Institute"

Graduate Students Receive Top Awards at Neuron 2023

April 27, 2023 URI neuroscience graduate students Emily Potts and Michelle Gregoire received awards at the Neuron 2023 research conference at Quinnipiac University’s Frank H. Netter MD School of Medicine on Sunday, April 23. The event was co-sponsored by the University of Connecticut. Students from the labs of Ryan Institute assistant professors Claudia Fallini and […]

Continue reading "Graduate Students Receive Top Awards at Neuron 2023"

Looking to spinal motor neurons to investigate the mysteries of ALS

Using his unique in vivo approach, Assistant Professor Marin Manuel investigates electrical activity in the spinal motor neurons in a disease model of amyotrophic lateral sclerosis. Also known as Lou Gehrig’s disease, amyotrophic lateral sclerosis (ALS) is a mysterious and fatal disorder where nerve cells in the brain and spinal cord break down, rapidly progressing […]

Continue reading "Looking to spinal motor neurons to investigate the mysteries of ALS"